Richard Thomason, MD
Pain Medicine · Tuscaloosa, ALNPI 1396951596
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,367 of the $4,485 with a category attached, or 75.1%. Boston Scientific accounts for 63.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2020 at $1,715 and has fallen 75.2% since, to $425 in 2025.
Across 200 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Vertos Medical, Inc.$592
- Amgen$246
- Collegium Pharmaceutical, Inc.$114
- Pacira Therapeutics, Inc.$94
- Johnson & Johnson$94
- plus $505 from 15 others
What the payments were for
- Travel & lodging$1,10625%
- Food & beverage$3,36775%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 103 | $2,839 |
| Vertos Medical, Inc. | 35 | $592 |
| Amgen(2 entities) | 18 | $246 |
| Collegium Pharmaceutical, Inc. | 8 | $114 |
| Pacira Therapeutics, Inc. | 5 | $94 |
| Johnson & Johnson | 1 | $94 |
| Redhill Biopharma Inc. | 5 | $74 |
| Pfizer | 5 | $68 |
| Forte Bio-pharma LLC | 2 | $63 |
| Abbott | 2 | $56 |
| Vertex | 2 | $38 |
| SPR Therapeutics, Inc | 1 | $31 |
| Almatica Pharma LLC | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Tersera Therapeutics LLC | 2 | $24 |
| Relievant Medsystems, Inc. | 1 | $21 |
| Pernix Therapeutics Holdings, Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,150
- PRECISION$299
How this compares
$4,485 in reported general payments places this provider in the 75th percentile of 77 pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 194 | $80,634 |
| Tramadol Hcl ErTramadol Hcl | 462 | $32,342 |
| Oxymorphone Hcl ErOxymorphone Hcl | 62 | $31,282 |
| Nucynta ErTapentadol Hcl | 12 | $18,741 |
| Fentanyl | 129 | $14,760 |
| Morphine Sulfate ErMorphine Sulfate | 580 | $11,819 |
| Gabapentin | 877 | $10,127 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,368 | $9,641 |
| Buprenorphine | 44 | $8,530 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 949 | $7,657 |
| OxycontinOxycodone Hcl | 17 | $5,088 |
| Methocarbamol | 495 | $3,334 |
| Diclofenac Sodium | 46 | $2,089 |
| Lidocaine | 28 | $1,998 |
| Chlorzoxazone | 51 | $1,767 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er | $114 | $99,375206 claims |
| Almatica Pharma LLCSertraline Hcl | $27 | $4211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 77 pain medicine providers in Alabama.
Other pain medicine in Tuscaloosa
- David NixonTuscaloosa$200
- Christopher PaulBirmingham$64K
- Michael CosgroveHuntsville$25K
- Ron PitkanenMountain Brk$16K
- Elliott PenningtonDaphne$15K
- James ThackerHuntsville$13K
- Grant StoneMobile$11K
- Hayden HundleyDothan$11K
- Hugh MaddoxAnniston$10K
- Jeremy BarlowVestavia Hills$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.